CN Stock MarketDetailed Quotes

688166 Brightgene Bio-Medical Technology Co.,Ltd.

Watchlist
  • 31.22
  • -2.34-6.97%
Market Closed Nov 15 15:00 CST
13.19BMarket Cap70.16P/E (TTM)

Brightgene Bio-Medical Technology Co.,Ltd. Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Total operating revenue
6.77%976.83M
11.95%657.69M
11.54%340.13M
15.94%1.18B
18.46%914.88M
17.41%587.48M
22.77%304.94M
-3.33%1.02B
3.19%772.32M
4.43%500.35M
Operating revenue
6.77%976.83M
11.95%657.69M
11.54%340.13M
15.94%1.18B
18.46%914.88M
17.41%587.48M
22.77%304.94M
-3.33%1.02B
3.19%772.32M
4.43%500.35M
Total operating cost
14.11%798.34M
19.72%554.21M
16.64%267.34M
25.15%980.32M
23.89%699.6M
20.45%462.93M
26.32%229.2M
-0.78%783.33M
4.30%564.69M
8.62%384.34M
Operating cost
8.26%410.24M
13.81%294.02M
16.19%145.69M
38.56%521.41M
30.85%378.94M
35.70%258.34M
38.61%125.39M
-18.32%376.3M
-8.19%289.61M
-8.71%190.38M
Operating tax surcharges
14.60%5.07M
9.84%3.15M
12.95%1.58M
9.35%5.71M
33.21%4.42M
68.82%2.87M
142.25%1.39M
23.66%5.22M
17.70%3.32M
-11.92%1.7M
Operating expense
24.69%56.24M
39.50%39.64M
-10.54%14.81M
-8.60%64.07M
-25.16%45.1M
-38.65%28.42M
0.40%16.56M
63.74%70.09M
168.00%60.27M
194.12%46.32M
Administration expense
1.95%84.73M
7.66%55.78M
0.93%28.54M
1.31%116.4M
7.71%83.11M
4.45%51.81M
21.43%28.28M
11.81%114.89M
5.33%77.16M
11.56%49.6M
Financial expense
22.61%29.69M
4.17%18.86M
30.84%11.67M
146.34%24.14M
613.79%24.21M
625.93%18.11M
13.16%8.92M
70.73%9.8M
-161.77%-4.71M
-34.50%2.49M
-Interest expense (Financial expense)
17.92%39.58M
15.17%27.57M
30.15%13.91M
87.36%44.42M
214.91%33.57M
202.32%23.94M
9.58%10.69M
144.54%23.71M
22.10%10.66M
60.50%7.92M
-Interest Income (Financial expense)
15.49%-8.79M
5.79%-7.01M
48.52%-1.54M
-703.62%-17.99M
-707.35%-10.4M
-985.37%-7.45M
-126.80%-2.99M
-146.09%-2.24M
-87.32%-1.29M
-37.59%-686.02K
Research and development
29.65%212.38M
38.09%142.76M
33.68%65.05M
20.08%248.59M
17.81%163.82M
10.16%103.39M
13.85%48.66M
19.47%207.02M
16.09%139.05M
18.29%93.85M
Credit Impairment Loss
-5.37%-7.25M
-16.91%-4.42M
-49.71%125.75K
-279.70%-2.47M
-146.30%-6.88M
18.84%-3.78M
119.38%250.04K
113.33%1.37M
60.32%-2.79M
31.54%-4.66M
Asset Impairment Loss
35.49%-5.23M
35.49%-5.23M
----
-46.70%-21.49M
-13.46%-8.11M
-13.46%-8.11M
----
-55.91%-14.65M
-1,549.30%-7.15M
-2,142.32%-7.15M
Other net revenue
Fair value change income
295.29%1.01M
-189.76%-1.56M
-840.99%-2.48M
84.68%-520.01K
109.73%255.43K
-50.95%1.74M
228.34%334.71K
-529.84%-3.39M
-20,533.24%-2.62M
1,031.75%3.55M
Invest income
-16.96%-9.63M
-36.98%-6.58M
-192.83%-4.55M
-472.54%-14.74M
-189.46%-8.24M
-146.38%-4.81M
-144.26%-1.55M
-57.14%3.96M
305.80%9.21M
516.90%10.36M
-Including: Investment income associates
4.50%-7.16M
-5.48%-4.9M
-135.05%-3.41M
-52.58%-13.61M
-63.55%-7.5M
-49.21%-4.65M
---1.45M
3.46%-8.92M
29.55%-4.58M
18.56%-3.11M
Asset deal income
----
----
----
----
----
----
----
57.00%9.89K
--0
----
Other revenue
94.09%10.97M
120.71%8.72M
472.38%4.8M
45.12%30.27M
-28.85%5.65M
45.61%3.95M
54.25%838.63K
263.52%20.86M
76.64%7.95M
-36.19%2.71M
Operating profit
-14.96%168.35M
-16.86%94.4M
-6.50%70.69M
-21.44%190.24M
-6.72%197.96M
-6.03%113.54M
15.80%75.61M
-6.50%242.16M
6.34%212.21M
1.06%120.83M
Add:Non operating Income
-81.97%35.09K
151.43%28.59K
358,861.36%6.32K
-81.06%199.02K
-81.93%194.61K
-98.67%11.37K
-99.99%1.76
882.79%1.05M
1,953.19%1.08M
2,471.72%854.31K
Less:Non operating expense
-33.09%309.66K
-57.05%119.57K
--111.08K
67.50%1.67M
-41.68%462.78K
-37.76%278.41K
----
-39.20%999.01K
-49.66%793.53K
-70.67%447.32K
Total profit
-14.98%168.08M
-16.75%94.31M
-6.64%70.59M
-22.06%188.77M
-6.97%197.69M
-6.57%113.28M
15.78%75.61M
-5.92%242.21M
7.30%212.5M
2.68%121.24M
Less:Income tax cost
1.77%21.32M
-18.86%12.08M
-8.20%8.78M
-50.14%15.35M
-39.49%20.95M
-13.13%14.89M
27.50%9.56M
54.70%30.78M
26.98%34.62M
16.22%17.14M
Net profit
-16.96%146.76M
-16.43%82.23M
-6.41%61.81M
-17.97%173.42M
-0.64%176.74M
-5.49%98.39M
14.26%66.04M
-11.00%211.43M
4.16%177.88M
0.75%104.11M
Net profit from continuing operation
-16.96%146.76M
-16.43%82.23M
-6.41%61.81M
-17.97%173.42M
-0.64%176.74M
-5.49%98.39M
14.26%66.04M
-11.00%211.43M
4.16%177.88M
0.75%104.11M
Less:Minority Profit
-103.66%-30.65M
-118.42%-24.14M
52.17%-2.26M
-3.00%-29.04M
23.78%-15.05M
-39.96%-11.05M
-59.97%-4.72M
-341.03%-28.2M
-224.17%-19.75M
-123.31%-7.9M
Net profit of parent company owners
-7.50%177.41M
-2.81%106.36M
-9.47%64.07M
-15.51%202.47M
-2.95%191.79M
-2.29%109.44M
16.48%70.77M
-1.77%239.62M
11.73%197.62M
4.80%112M
Earning per share
Basic earning per share
-6.67%0.42
-3.85%0.25
-11.76%0.15
-17.24%0.48
-6.25%0.45
-3.70%0.26
13.33%0.17
-3.33%0.58
11.63%0.48
3.85%0.27
Diluted earning per share
-6.67%0.42
-3.85%0.25
-11.76%0.15
-17.24%0.48
-6.25%0.45
-3.70%0.26
13.33%0.17
-3.33%0.58
11.63%0.48
3.85%0.27
Other composite income
-614.69%-35.07M
-766.40%-35.14M
-2.29M
22.82%-26.4M
-2,417.43%-4.91M
-548.86%-4.06M
-3,236.33%-34.2M
270.05%211.75K
227.26%903.5K
Other composite income of parent company owners
-614.69%-35.07M
-766.40%-35.14M
---2.29M
22.82%-26.4M
-2,417.43%-4.91M
-548.86%-4.06M
----
-3,236.33%-34.2M
270.05%211.75K
227.26%903.5K
Total composite income
-35.00%111.69M
-50.08%47.09M
-9.87%59.52M
-17.04%147.02M
-3.51%171.83M
-10.17%94.33M
14.26%66.04M
-25.07%177.22M
4.36%178.09M
2.33%105.01M
Total composite income of parent company owners
-23.84%142.34M
-32.41%71.23M
-12.70%61.78M
-14.29%176.07M
-5.54%186.88M
-6.66%105.38M
16.48%70.77M
-15.44%205.42M
11.93%197.84M
6.36%112.9M
Total composite income of minority owners
-103.66%-30.65M
-118.42%-24.14M
52.17%-2.26M
-3.00%-29.04M
23.78%-15.05M
-39.96%-11.05M
-59.97%-4.72M
-341.03%-28.2M
-224.17%-19.75M
-123.31%-7.9M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Notarized Tianye Certified Public Accountants Firm (Special General Partnership)
--
--
--
Notarized Tianye Certified Public Accountants Firm (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Total operating revenue 6.77%976.83M11.95%657.69M11.54%340.13M15.94%1.18B18.46%914.88M17.41%587.48M22.77%304.94M-3.33%1.02B3.19%772.32M4.43%500.35M
Operating revenue 6.77%976.83M11.95%657.69M11.54%340.13M15.94%1.18B18.46%914.88M17.41%587.48M22.77%304.94M-3.33%1.02B3.19%772.32M4.43%500.35M
Total operating cost 14.11%798.34M19.72%554.21M16.64%267.34M25.15%980.32M23.89%699.6M20.45%462.93M26.32%229.2M-0.78%783.33M4.30%564.69M8.62%384.34M
Operating cost 8.26%410.24M13.81%294.02M16.19%145.69M38.56%521.41M30.85%378.94M35.70%258.34M38.61%125.39M-18.32%376.3M-8.19%289.61M-8.71%190.38M
Operating tax surcharges 14.60%5.07M9.84%3.15M12.95%1.58M9.35%5.71M33.21%4.42M68.82%2.87M142.25%1.39M23.66%5.22M17.70%3.32M-11.92%1.7M
Operating expense 24.69%56.24M39.50%39.64M-10.54%14.81M-8.60%64.07M-25.16%45.1M-38.65%28.42M0.40%16.56M63.74%70.09M168.00%60.27M194.12%46.32M
Administration expense 1.95%84.73M7.66%55.78M0.93%28.54M1.31%116.4M7.71%83.11M4.45%51.81M21.43%28.28M11.81%114.89M5.33%77.16M11.56%49.6M
Financial expense 22.61%29.69M4.17%18.86M30.84%11.67M146.34%24.14M613.79%24.21M625.93%18.11M13.16%8.92M70.73%9.8M-161.77%-4.71M-34.50%2.49M
-Interest expense (Financial expense) 17.92%39.58M15.17%27.57M30.15%13.91M87.36%44.42M214.91%33.57M202.32%23.94M9.58%10.69M144.54%23.71M22.10%10.66M60.50%7.92M
-Interest Income (Financial expense) 15.49%-8.79M5.79%-7.01M48.52%-1.54M-703.62%-17.99M-707.35%-10.4M-985.37%-7.45M-126.80%-2.99M-146.09%-2.24M-87.32%-1.29M-37.59%-686.02K
Research and development 29.65%212.38M38.09%142.76M33.68%65.05M20.08%248.59M17.81%163.82M10.16%103.39M13.85%48.66M19.47%207.02M16.09%139.05M18.29%93.85M
Credit Impairment Loss -5.37%-7.25M-16.91%-4.42M-49.71%125.75K-279.70%-2.47M-146.30%-6.88M18.84%-3.78M119.38%250.04K113.33%1.37M60.32%-2.79M31.54%-4.66M
Asset Impairment Loss 35.49%-5.23M35.49%-5.23M-----46.70%-21.49M-13.46%-8.11M-13.46%-8.11M-----55.91%-14.65M-1,549.30%-7.15M-2,142.32%-7.15M
Other net revenue
Fair value change income 295.29%1.01M-189.76%-1.56M-840.99%-2.48M84.68%-520.01K109.73%255.43K-50.95%1.74M228.34%334.71K-529.84%-3.39M-20,533.24%-2.62M1,031.75%3.55M
Invest income -16.96%-9.63M-36.98%-6.58M-192.83%-4.55M-472.54%-14.74M-189.46%-8.24M-146.38%-4.81M-144.26%-1.55M-57.14%3.96M305.80%9.21M516.90%10.36M
-Including: Investment income associates 4.50%-7.16M-5.48%-4.9M-135.05%-3.41M-52.58%-13.61M-63.55%-7.5M-49.21%-4.65M---1.45M3.46%-8.92M29.55%-4.58M18.56%-3.11M
Asset deal income ----------------------------57.00%9.89K--0----
Other revenue 94.09%10.97M120.71%8.72M472.38%4.8M45.12%30.27M-28.85%5.65M45.61%3.95M54.25%838.63K263.52%20.86M76.64%7.95M-36.19%2.71M
Operating profit -14.96%168.35M-16.86%94.4M-6.50%70.69M-21.44%190.24M-6.72%197.96M-6.03%113.54M15.80%75.61M-6.50%242.16M6.34%212.21M1.06%120.83M
Add:Non operating Income -81.97%35.09K151.43%28.59K358,861.36%6.32K-81.06%199.02K-81.93%194.61K-98.67%11.37K-99.99%1.76882.79%1.05M1,953.19%1.08M2,471.72%854.31K
Less:Non operating expense -33.09%309.66K-57.05%119.57K--111.08K67.50%1.67M-41.68%462.78K-37.76%278.41K-----39.20%999.01K-49.66%793.53K-70.67%447.32K
Total profit -14.98%168.08M-16.75%94.31M-6.64%70.59M-22.06%188.77M-6.97%197.69M-6.57%113.28M15.78%75.61M-5.92%242.21M7.30%212.5M2.68%121.24M
Less:Income tax cost 1.77%21.32M-18.86%12.08M-8.20%8.78M-50.14%15.35M-39.49%20.95M-13.13%14.89M27.50%9.56M54.70%30.78M26.98%34.62M16.22%17.14M
Net profit -16.96%146.76M-16.43%82.23M-6.41%61.81M-17.97%173.42M-0.64%176.74M-5.49%98.39M14.26%66.04M-11.00%211.43M4.16%177.88M0.75%104.11M
Net profit from continuing operation -16.96%146.76M-16.43%82.23M-6.41%61.81M-17.97%173.42M-0.64%176.74M-5.49%98.39M14.26%66.04M-11.00%211.43M4.16%177.88M0.75%104.11M
Less:Minority Profit -103.66%-30.65M-118.42%-24.14M52.17%-2.26M-3.00%-29.04M23.78%-15.05M-39.96%-11.05M-59.97%-4.72M-341.03%-28.2M-224.17%-19.75M-123.31%-7.9M
Net profit of parent company owners -7.50%177.41M-2.81%106.36M-9.47%64.07M-15.51%202.47M-2.95%191.79M-2.29%109.44M16.48%70.77M-1.77%239.62M11.73%197.62M4.80%112M
Earning per share
Basic earning per share -6.67%0.42-3.85%0.25-11.76%0.15-17.24%0.48-6.25%0.45-3.70%0.2613.33%0.17-3.33%0.5811.63%0.483.85%0.27
Diluted earning per share -6.67%0.42-3.85%0.25-11.76%0.15-17.24%0.48-6.25%0.45-3.70%0.2613.33%0.17-3.33%0.5811.63%0.483.85%0.27
Other composite income -614.69%-35.07M-766.40%-35.14M-2.29M22.82%-26.4M-2,417.43%-4.91M-548.86%-4.06M-3,236.33%-34.2M270.05%211.75K227.26%903.5K
Other composite income of parent company owners -614.69%-35.07M-766.40%-35.14M---2.29M22.82%-26.4M-2,417.43%-4.91M-548.86%-4.06M-----3,236.33%-34.2M270.05%211.75K227.26%903.5K
Total composite income -35.00%111.69M-50.08%47.09M-9.87%59.52M-17.04%147.02M-3.51%171.83M-10.17%94.33M14.26%66.04M-25.07%177.22M4.36%178.09M2.33%105.01M
Total composite income of parent company owners -23.84%142.34M-32.41%71.23M-12.70%61.78M-14.29%176.07M-5.54%186.88M-6.66%105.38M16.48%70.77M-15.44%205.42M11.93%197.84M6.36%112.9M
Total composite income of minority owners -103.66%-30.65M-118.42%-24.14M52.17%-2.26M-3.00%-29.04M23.78%-15.05M-39.96%-11.05M-59.97%-4.72M-341.03%-28.2M-224.17%-19.75M-123.31%-7.9M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Notarized Tianye Certified Public Accountants Firm (Special General Partnership)------Notarized Tianye Certified Public Accountants Firm (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data